Cyclosporine inhibits hepatitis C virus in vitro (Hep C Chronic Fatigue)

Cyclosporine inhibits hepatitis C virus in vitro
EurekAlert - Liver transplant patients with hepatitis C virus (HCV) achieved significantly better long-term viral response when taking the immunosuppressive agent Cyclosporine along with interferon-ribavirin combination therapy. Cyclosporine also showed efficacy

Hepatitis C Patients Taxing Medical System
HealthScout - FRIDAY, Dec. 30 (HealthDay News) -- The use of health-care resources by hepatitis C patients in the United States has been increasing by 25 percent to 30 percent a year, says a Duke University study in the December issue of Hepatology . About 3

Nonalcoholic Fatty Liver Disease -- New Insight Into a Major Cause of
Medscape News - Research presented during this year's meeting of the American Association for the Study of Liver Diseases (AASLD) addressed important advances in our understanding of the hepatic consequences of obesity -- nonalcoholic fatty liver disease (NAFLD), a

Interferon with Ribavirin is safe and effective for children with
Xagena Medical News - Nearly half of 118 children with chronic Hepatitis C virus ( HCV ) treated with a combination of Interferon-alpha-2b ( Intron A ) and an optimized dose of Ribavirin ( Rebetol ) achieved sustained viral response, and side effects were generally mild

Chronic Hepatitis C Treatment, Peg-Intron(R) And Rebetol(R) Approved
Medical News Today - Schering-Plough Corporation (NYSE: SGP) announced that Schering-Plough K.K., the company's country operations in Japan, has received marketing approval for a new, additional indication for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection in